<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04722926</url>
  </required_header>
  <id_info>
    <org_study_id>268</org_study_id>
    <nct_id>NCT04722926</nct_id>
  </id_info>
  <brief_title>Lyon PJI Retrospective Cohort Study</brief_title>
  <official_title>Lyon Prosthetic Joint Infection Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bone and joint infections (BJI), although infrequent (prevalence of 70 per 100,000 in&#xD;
      France), have a significant economic and clinical impact. Between 2008 and 2013, the&#xD;
      prevalence of BJI increased and infections involving joint prosthesis (PJI) represent a third&#xD;
      of BJI in France. They are most often post-operative and more expensive than native IOAs.&#xD;
&#xD;
      This study aims to describe PJI and understand the failure mechanisms of PJI in order to&#xD;
      improve their management.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>rate of PJI</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>proportion of PJI among all BJI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of PJI</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>acute/chronic</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of type of prosthesis PJI</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>number of prosthesis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of patients having had a PJI</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>type of patients: age</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of comorbidities of patients having had a PJI</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>type of comorbidities..</description>
  </primary_outcome>
  <primary_outcome>
    <measure>rate of bacteria</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>epidemiologic description of PJI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>description of antibiotic used</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>type of antibiotic : name</description>
  </primary_outcome>
  <primary_outcome>
    <measure>description of antibiotic treatment</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>duration of antibiotic treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>description of surgical treatment</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>type of surgery: 1-step exchange, 2- step exchange, DAIR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of failure</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>proportion of patients having a failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>description of the failure</measure>
    <time_frame>between 2018 and 2020</time_frame>
    <description>type of failure : persistence or surinfection and management of failure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Bone and Joint Infection</condition>
  <arm_group>
    <arm_group_label>PJI</arm_group_label>
    <description>Patients having had a PJI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PJI</intervention_name>
    <description>patients having had a PJI managed at the CRIOAc Lyon, with or without relapse</description>
    <arm_group_label>PJI</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients having had a PJI between 2018 and 2020 managed at the CRIOAc Lyon&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients having had a PJI between 2018 and 2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Eugenie Mabrut, CRA</last_name>
    <phone>. 04 26 73 29 38</phone>
    <email>eugenie.mabrut@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tristan Ferry, MD,PhD</last_name>
    <phone>. 04 26 73 29 38</phone>
    <email>tristan.ferry@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>https://www.crioac-lyon.fr/</url>
    <description>Related Info</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 15, 2021</study_first_submitted>
  <study_first_submitted_qc>January 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prosthesis joint infection</keyword>
  <keyword>relapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Arthritis, Infectious</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

